Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient

Ye Won Chung, Hyo Sook Bae, Jae Yun Song, Jae Kwan Lee, Nak Woo Lee, Tak Kim, Kyu Wan Lee

    Research output: Contribution to journalArticlepeer-review

    119 Citations (Scopus)


    Objective: MicroRNA (miRNA) is an abundant class of small noncoding RNAs that act as gene regulators. Recent studies have suggested thatmiRNA deregulation is associated with the initiation and progression of human cancer. However, information about cancer-related miRNA is mostly limited to tissue miRNA. The aim of this study was to find specific profiles of serum-derived miRNAsof ovarian cancer based on a comparative study using amiRNA microarray of serum, tissue, and ascites. Methods: From 2 ovarian cancer patients and a healthy control, total RNAwas isolated from their serum, tissue, and ascites, respectively, and analyzed by a microarray. Under the comparative study of eachmiRNAmicroarray,we sorted out severalmiRNAs showing a consistent regulation tendency throughout all 3 specimens and the greatest range of alteration in serum as potential biomarkers. The availability of biomarkerswas confirmed by qRT-PCRof 18 patients and 12 controls. Results: Out of 2222 kinds of total miRNAs that were identified in the microarray analysis, 95 miRNAs were down-regulated and 88 miRNAs were up-regulated, in the serum, tissue, and ascites of cancer patients. Among the miRNAs that showed a consistent regulation tendency through all specimens and showed more than a 2-fold difference in serum, 5 miRNAs (miR-132, miR-26a, let-7b, miR-145, and miR-143) were determined as the 5 most markedly down-regulated miRNAs in the serum from ovarian cancer patients with respect to those of controls. Four miRNAs (miR-132, miR-26a, let-7b, and miR-145) out of 5 selected miRNAs were significantly underexpressed in the serum of ovarian cancer patients in qRT-PCR. Conclusions: Serum miR-132, miR-26a, let-7b, and miR-145 could be considered as potential candidates as novel biomarkers in serous ovarian cancer. Also, serum miRNAs is a promising and useful tool for discriminating between controls and patientswith serous ovarian cancer.

    Original languageEnglish
    Pages (from-to)673-679
    Number of pages7
    JournalInternational Journal of Gynecological Cancer
    Issue number4
    Publication statusPublished - 2013 May


    • Biological markers
    • MicroRNAs
    • Ovarian neoplasms

    ASJC Scopus subject areas

    • Oncology
    • Obstetrics and Gynaecology


    Dive into the research topics of 'Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient'. Together they form a unique fingerprint.

    Cite this